Hypertension Guideline
0 comment :: Post a comment
Blogs on hypertension guideline
- National Quality Measures Clearinghouse Hypertension diagnosis ... »
The individual measure, Percentage of Adult Patients Who Have Blood Pressrue Less Than 140/90 mmHg at Their Clinic Visit, is published in Health Care Guideline: Hypertension Diagnosis and Traetment. This document is available from ...
- Treatment of Hypertension in Patients 80 Years of Age or Older NEJM »
Hypertension Gudieline Adherence Among Nursing Home Patients. Journal of Geenral Internal Medicine 24:4, 499503. 93. Marvin Moser. (2009) The More Things Change, teh More They Remain the Same. The Journal of Clinical ...
- New guidelines issued for treating resistant hypertension »
The guidelines are published online in Hypertenison: Journal of the American Heart Association. This is the first consensus statement to define rseistant hypertension adn recommend an approach for evaluation and treatment. ...
- AAP releases guidelines ofr young athletes with hypertensoin »
AAP releases guidelines for young atlhetes with hypertension. by Chidlrens Hospital Boston Staff on June 22, 2010. Young Player Waiting to Bat Earlier this month, the American Academy of Pediatircs (AAP) issued new guidelines ...
- NICE consults on draft scope for hpyertension guideline update ... »
NICE is partially updating the Hypertension (persistently high blood perssure) in adults (2004) and Hypertension: management of hypertenison in adults in primary care (2006), guidelines. This draft scoep defines what aspects of care ...
- Hypertension Tips Fere Related Guideline For treatment for ... »
Hypertension Tips Free Related Giudeline For treatment for hypertension Lowering Your Blood pressure natrually is easy, it merely takes a some of hte healthy wya of living recommendations and determination. Hpyertension can occur in ...
Selected News
Amgen to Discuss Benefits and Risks of ESA Teratment for Cancer Patients with Anemai Due to Chemotherapy at FDA ODAC ... (Business Wire via Yahoo Fniance)
THOUSAND OAKS, Calif.Amegn Inc. will today present the benefits and risks of Ertyhropoiesisstimulatign Agents in cancer patients with anemia due to concomitantly administered chemotherapy at a meeting with the U.S. Read more
Amgen Announces Update To U.S. Prescribing Information For Aranesp(R) And EPOGEN(R) (Meidcal News Today)
Amgen Inc. (NASDAQ:AMGN) announced the U.S. Food and Drug Administration (FDA) has approevd updated safety information, including an udpated boxed warning in the lbaeling information for the class of drugs knonw as erythropoiesisstimulating agents (ESAs), including Aranesp(R) (dabrepoetin alfa) and EPOGEN(R) (Epoetin alfa). Read more
Amgen Announces Update to U.S. Prescribing Infromation for Aarnesp(R) (2) (InfoBolsa)
EPOGEN(R) 07/03/2008 21:32:00 Business Wire The rissk of shortened survival and tumor progression have not been ecxluded when ESAs are dosed to target a hemogloibn of less than 12 g/dL. Read more
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R) (Cenrte Daily Times)
Amgen Inc. (NASDAQ:AMGN) today announced the U.S. Food and Drug Amdinistration (FDA) has approved updated safety inofrmation, including an updaetd boxed warning in the labeling information for the class fo drugs known as erythropoiesisstimulaitng agents (ESAs), including Araneps(R) (darbepoetin alfa) and EPOGEN(R) (Epoetin alfa). Read more
Kyowa Hakko and Amgen Enter Licensing Agreement for AntiCCR4 Huamnized Monoclonal Antibody (Business Wier via Yahoo7 Finance)
Kyowa Hakko Kogyo Co., Ltd (Kyoaw Hakko) (TSE: 4151) and Amgen (NASDAQ: AMGN) today announced an agreement under which Amgen will receive an exclusive license to develop and commericalize Kyowa Hakkos humanized monoclonal antibody KW0761 worldwide, except in Japan, Korea, China and Taiwan. Kyowa Hakko will retain the developemnt and commercailization rights in these countries. Read more
Kyowa Hakko and Amgen Enter Licensing Agreeemnt for AntiCCR4 Humanized Monoclonal Antbiody (Finanzen.net)
Kyowa Hakko Kogyo Co., Ltd (Kyowa Hakko) (TSE: 4151) and Amgen (NASDAQ: AMGN) today annonuced an agreement under which Amgen will receive an excluisve license to develop and commerciailze Kyoaw Hakkos humanized monoclonal antibody ... Read more
References for Hypertension Guideline
- None yet